Kiniksa Pharmaceuticals Ltd (KNSA)
20.33
+0.34
(+1.70%)
USD |
NASDAQ |
May 07, 16:00
20.33
0.00 (0.00%)
After-Hours: 16:11
Kiniksa Pharmaceuticals Market Cap: 1.442B for May 7, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 06, 2024 | 1.418B |
| May 03, 2024 | 1.424B |
| May 02, 2024 | 1.375B |
| May 01, 2024 | 1.376B |
| April 30, 2024 | 1.328B |
| April 29, 2024 | 1.316B |
| April 26, 2024 | 1.268B |
| April 25, 2024 | 1.249B |
| April 24, 2024 | 1.267B |
| April 23, 2024 | 1.254B |
| April 22, 2024 | 1.213B |
| April 19, 2024 | 1.200B |
| April 18, 2024 | 1.197B |
| April 17, 2024 | 1.202B |
| April 16, 2024 | 1.239B |
| April 15, 2024 | 1.237B |
| April 12, 2024 | 1.224B |
| April 11, 2024 | 1.253B |
| April 10, 2024 | 1.236B |
| April 09, 2024 | 1.256B |
| April 08, 2024 | 1.252B |
| April 05, 2024 | 1.268B |
| April 04, 2024 | 1.279B |
| April 03, 2024 | 1.292B |
| April 02, 2024 | 1.326B |
| Date | Value |
|---|---|
| April 01, 2024 | 1.395B |
| March 28, 2024 | 1.393B |
| March 27, 2024 | 1.412B |
| March 26, 2024 | 1.410B |
| March 25, 2024 | 1.409B |
| March 22, 2024 | 1.410B |
| March 21, 2024 | 1.398B |
| March 20, 2024 | 1.397B |
| March 19, 2024 | 1.391B |
| March 18, 2024 | 1.383B |
| March 15, 2024 | 1.412B |
| March 14, 2024 | 1.437B |
| March 13, 2024 | 1.445B |
| March 12, 2024 | 1.443B |
| March 11, 2024 | 1.436B |
| March 08, 2024 | 1.469B |
| March 07, 2024 | 1.501B |
| March 06, 2024 | 1.483B |
| March 05, 2024 | 1.425B |
| March 04, 2024 | 1.426B |
| March 01, 2024 | 1.535B |
| February 29, 2024 | 1.493B |
| February 28, 2024 | 1.438B |
| February 27, 2024 | 1.475B |
| February 26, 2024 | 1.424B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
287.53M
Minimum
Oct 18 2019
1.636B
Maximum
Feb 19 2021
973.64M
Average
968.79M
Median
Market Cap Benchmarks
| Amicus Therapeutics Inc | 3.079B |
| Geron Corp | 2.292B |
| United Therapeutics Corp | 11.82B |
| Vanda Pharmaceuticals Inc | 314.44M |
| TG Therapeutics Inc | 2.651B |
Market Cap Related Metrics
| PE Ratio | 184.82 |
| PS Ratio | 4.889 |
| Price to Book Value | 3.339 |
| Price to Free Cash Flow | 69.06 |
| Price | 20.33 |
| Earnings Yield | 0.54% |
| Normalized PE Ratio | 184.82 |